v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
At Market Issuance Sales Agreement
Common Stock
Common Stock
At Market Issuance Sales Agreement
Additional Paid-in Capital
Additional Paid-in Capital
At Market Issuance Sales Agreement
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023     88,869,463          
Beginning balance at Dec. 31, 2023 $ 59,800   $ 9   $ 189,454   $ 0 $ (129,663)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost (in shares)       14,701,388        
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost   $ 33,263   $ 2   $ 33,261    
Issuance of common stock upon exercise of stock warrants, net of issuance cost (in shares)     13,075,664          
Issuance of common stock upon exercise of stock warrants, net of issuance cost 13,628   $ 2   13,626      
Issuance of common stock upon exchange of stock warrants for shares of common stock (in shares)     3,073,200          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     2,714,599          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 109       109      
Cancellation and retirement of common stock (in shares)     (5,500,000)          
Cancellation and retirement of common stock (in shares)     $ (1)   1      
Stock-based compensation 7,343       7,343      
Net loss $ (44,671)             (44,671)
Ending balance (in shares) at Dec. 31, 2024 116,934,314   116,934,314          
Ending balance at Dec. 31, 2024 $ 69,472   $ 12   243,794   0 (174,334)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost (in shares)       10,719,196        
Issuance of common stock in connection with the At Market Issuance Sales Agreement, net of issuance cost   $ 63,581   $ 1   $ 63,580    
Issuance of common stock upon exchange of stock warrants for shares of common stock (in shares)     200,100          
Issuance of common stock upon exchange of stock warrants for shares of common stock 2,301       2,301      
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)     6,682,982          
Issuance of common stock upon exercise of stock options and vesting of restricted stock units 5,071       5,071      
Stock-based compensation 7,410       7,410      
Net loss (44,024)             (44,024)
Other comprehensive income $ 4           4  
Ending balance (in shares) at Dec. 31, 2025 134,536,592   134,536,592          
Ending balance at Dec. 31, 2025 $ 103,815   $ 13   $ 322,156   $ 4 $ (218,358)